Enteral administration of alectinib for ALK-positive non-small cell lung cancer in an elderly patient: A case report.

Quentin Dominique ThomasMarie PautasMarie-Noëlle GuilhaumeFréderic FiteniTony GeNicolas Girard

Published in: Medicine (2021)

In cases of lung cancer with oncogenic addiction, enteral administration of TKIs should be considered for elderly patients with an impaired general condition.

Keyphrases

middle aged
community dwelling
case report
transcription factor
advanced non small cell lung cancer